Evidence that elevated lipoprotein (a)(Lp [a]) levels contribute to cardiovascular disease
(CVD) and calcific aortic valve stenosis (CAVS) is substantial. Development of isoform …

Pathophysiological, epidemiological, and genetic studies provide strong evidence that
lipoprotein (a)[Lp (a)] is a causal mediator of cardiovascular disease (CVD) and calcific …

The emergence of pathophysiological, epidemiologic, and genetic data strongly supports
the causality for lipoprotein (a)[Lp (a)] in cardiovascular disease (CVD) and calcific aortic …

Recently published epidemiological and genetic studies strongly suggest a causal
relationship of elevated concentrations of lipoprotein (a)[Lp (a)] with cardiovascular disease …

Abstract Lipoprotein (a)[Lp (a)] is a highly heritable cardiovascular risk factor. Although
discovered more than 50 years ago, Lp (a) has recently re-emerged as a major focus in the …

Lipoprotein (a)(Lp (a)) is an established risk factor for multiple cardiovascular diseases.
Several lines of evidence including mechanistic, epidemiologic, and genetic studies support …

Importance Lipoprotein (a)(Lp [a]) is a low-density lipoprotein (LDL) cholesterol–like particle
bound to apolipoprotein (a). This novel marker of cardiovascular disease acts through …

Evidence from Mendelian randomization studies suggest that lipoprotein (a)(Lp (a)) has a
causal role in the development of atherosclerotic cardiovascular disease risk. However …

Aims To investigate the population attributable fraction due to elevated lipoprotein (a)(Lp (a))
and the utility of measuring Lp (a) in cardiovascular disease (CVD) risk prediction. Methods …

Lipoprotein (a)(Lp (a)) is a complex circulating lipoprotein, and increasing evidence has
demonstrated its role as a risk factor for atherosclerotic cardiovascular disease (ASCVD) …